These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 3547113)
21. Mutagenicity of pyrene in Salmonella. Matijasević Z; Zeiger E Mutat Res; 1985 Apr; 142(4):149-52. PubMed ID: 3885017 [TBL] [Abstract][Full Text] [Related]
22. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test. Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239 [TBL] [Abstract][Full Text] [Related]
23. Synergistic, additive, and antagonistic mutagenic responses to binary mixtures of benzo(a)pyrene and benzo(e)pyrene as detected by strains TA98 and TA100 in the Salmonella/microsome assay. Hass BS; Brooks EE; Schumann KE; Dornfeld SS Environ Mutagen; 1981; 3(2):159-66. PubMed ID: 6263605 [TBL] [Abstract][Full Text] [Related]
24. Retinol (vitamin A) inhibits the mutagenicity of o-aminoazotoluene activated by liver microsomes from several species in the Ames test. Victorin K; Busk L; Ahlborg UG Mutat Res; 1987 Jul; 179(1):41-8. PubMed ID: 3110607 [TBL] [Abstract][Full Text] [Related]
25. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and beta-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins. Raina V; Williams CJ; Gurtoo HL Biochem Pharmacol; 1983 Dec; 32(24):3755-63. PubMed ID: 6318770 [TBL] [Abstract][Full Text] [Related]
26. Mutagenesis in Salmonella after metabolic activation of carcinogenic azo dyes and their isomers by liver S9 from rats, mice and hamsters. Mori Y; Niwa T; Toyoshi K; Hirano K; Sugiura M Mutat Res; 1983 Aug; 121(2):95-102. PubMed ID: 6348534 [TBL] [Abstract][Full Text] [Related]
27. Mutagenicity studies on fenitrothion in bacteria and mammalian cells. Hara M; Kogiso S; Yamada F; Kawamoto M; Yoshitake A; Miyamoto J Mutat Res; 1989 Jan; 222(1):53-61. PubMed ID: 2643032 [TBL] [Abstract][Full Text] [Related]
28. The evaluation of mutagenicities of 19 structurally related aromatic amines and acetamides in Salmonella typhimurium TA98 and TA100. Connor TH; Ramanujam VM; Rinkus SJ; Legator MS; Trieff NM Mutat Res; 1983 Jul; 118(1-2):49-59. PubMed ID: 6346086 [TBL] [Abstract][Full Text] [Related]
29. H-2 modulation of aryl hydrocarbon hydroxylase induction and the mutagenicity of benzo(a)pyrene after 3-methylcholanthrene treatment. Brooks BA; Wassom DL; Babish JG Adv Exp Med Biol; 1986; 197():797-807. PubMed ID: 3532714 [TBL] [Abstract][Full Text] [Related]
30. Mutagenicity of 3-chlorodibenzofuran and its metabolic activation. Matsumoto M; Ando M Environ Mol Mutagen; 1991; 17(2):104-11. PubMed ID: 2009865 [TBL] [Abstract][Full Text] [Related]
31. Microsomal activation of dibenzo[def,mno]chrysene (anthanthrene), a hexacyclic aromatic hydrocarbon without a bay-region, to mutagenic metabolites. Platt KL; Degenhardt C; Grupe S; Frank H; Seidel A Chem Res Toxicol; 2002 Mar; 15(3):332-42. PubMed ID: 11896680 [TBL] [Abstract][Full Text] [Related]
32. Absence of mutagenicity of trioxane and dioxolane in Salmonella typhimurium. Kowalski Z; Spiechowicz E; Barański B Mutat Res; 1984 Jun; 136(3):169-71. PubMed ID: 6377055 [TBL] [Abstract][Full Text] [Related]
33. Mutagenicity of diphenylhydantoin and some of its metabolites towards salmonella typhimurium strains. Sezzano P; Raimondi A; Arboix M; Pantarotto C Mutat Res; 1982 Mar; 103(3-6):219-28. PubMed ID: 7045642 [TBL] [Abstract][Full Text] [Related]
34. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay. Anderson JG; McCalla DR; Bryant DW; McCarry BE; Bromke AM Mutagenesis; 1987 Jul; 2(4):279-85. PubMed ID: 3325759 [TBL] [Abstract][Full Text] [Related]
35. Some factors affecting mutant numbers in the Salmonella/microsome assay. Booth SC; Welch AM; Garner RC Carcinogenesis; 1980; 1(11):911-23. PubMed ID: 11219844 [TBL] [Abstract][Full Text] [Related]
36. Mutagenicity of 2,6-dinitrotoluene and its metabolites, and their related compounds in Salmonella typhimurium. Sayama M; Mori M; Shirokawa T; Inoue M; Miyahara T; Kozuka H Mutat Res; 1989 Jul; 226(3):181-4. PubMed ID: 2664501 [TBL] [Abstract][Full Text] [Related]
37. Mutagenicity of benzo[a]pyrene 7,8-dihydrodiol and 7,12-dimethylbenz[a]anthracene 3,4-dihydrodiol in S. typhimurium mediated by microsomes from rat liver and mouse skin. Camus AM; Pyerin WG; Grover PL; Sims P; Malaveille C; Bartsch H Chem Biol Interact; 1980 Nov; 32(3):257-65. PubMed ID: 6775825 [TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo benzo(a)pyrene metabolism in rat liver and lung microsomes: effect of sodium selenite. Bompart G; Clamens S J Toxicol Clin Exp; 1990; 10(1):3-14. PubMed ID: 2163448 [TBL] [Abstract][Full Text] [Related]
39. Rat nasal tissue activation of benzo(a)pyrene and 2-aminoanthracene to mutagens in Salmonella typhimurium. Bond JA; Li AP Environ Mutagen; 1983; 5(3):311-8. PubMed ID: 6303770 [TBL] [Abstract][Full Text] [Related]
40. Effect of dietary casein levels on activation of promutagens in the spiral Salmonella mutagenicity assay. II. Studies with induced rat liver S9. Woodall GM; Dauterman WC; DeMarini DM Mutat Res; 1996 Jun; 360(2):127-43. PubMed ID: 8649465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]